1. Home
  2. ICO Base
  3. BioNT

BioNT

Drugs & Healthcare

Overview

The BioNT team develops global drug pricing platform.

Features

The services that will be offered include: - Single global drug pricing platform - Disease and epidemiology database - Drug forecasting platform - Integrated – drug pricing and forecasting system through Blockchain - Securities trading signals

Crowdsale

Token Sale
ICO start date 19 Aug 2017
ICO end date 21 Oct 2017
Legal
ICO Platform No
Token details
Ticker BIONT
Additional Token Emission No
Accepted Currencies

ETH

Token distribution

126 million tokens available for the crowd sale campaign. 14 million tokens, with a 6 month lock up, are reserved for Advanced Intelligence GmbH and founders team. Funds allocaton: Enhancement and, Commercialization Beta Pricing Platform, 10% Development, 55% Legal, 5% Team Allocation, 10% Global Sales and Marketing, 20%

Ratings

Type of scores
Score
Status
Hype score Very Low Active
Risk score Medium Active

Team members

Name
Position
Score
Social
NA
NA
NA
NA

Funding Rounds

Rating Review and Analytics

Investment rating Info NA
Hype score Info Very Low
Risk score Info Medium
BioNT ICO Contacts
Website

Ended

Start ICO 19 Aug 2017
End ICO 21 Oct 2017
Token BIONT
MVP No
Whitepaper View
BioNT rating widget
Rating Get this widget
ICOs that might interest you

Status TBA
Hype score Medium
Risk score Medium
Investment rating Risky


Status TBA
Hype score High
Risk score Medium
Investment rating Risky


Status TBA
Hype score Medium
Risk score Low
Investment rating Stable


Status TBA
Hype score Medium
Risk score NA
Investment rating Stable